Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun 10;11(1):12237.
doi: 10.1038/s41598-021-91632-2.

Prediction of caregiver quality of life in amyotrophic lateral sclerosis using explainable machine learning

Affiliations

Prediction of caregiver quality of life in amyotrophic lateral sclerosis using explainable machine learning

Anna Markella Antoniadi et al. Sci Rep. .

Abstract

Amyotrophic Lateral Sclerosis (ALS) is a rare neurodegenerative, fatal and currently incurable disease. People with ALS need support from informal caregivers due to the motor and cognitive decline caused by the disease. This study aims to identify caregivers whose quality of life (QoL) may be impacted as a result of caring for a person with ALS. In this study, we worked towards the identification of the predictors of a caregiver's QoL in addition to the development of a model for clinical use to alert clinicians when a caregiver is at risk of experiencing low QoL. The data were collected through the Irish ALS Registry and via interviews on several topics with 90 patient and caregiver pairs at three time-points. The McGill QoL questionnaire was used to assess caregiver QoL-the MQoL Single Item Score measures the overall QoL and was selected as the outcome of interest in this work. The caregiver's existential QoL and burden, as well as the patient's depression and employment before the onset of symptoms were the features that had the highest impact in predicting caregiver quality of life. A small subset of features that could be easy to collect was used to develop a second model to use it in a clinical setting. The most predictive features for that model were the weekly caregiving duties, age and health of the caregiver, as well as the patient's physical functioning and age of onset.

PubMed Disclaimer

Conflict of interest statement

O.H. is a lead investigator on projects that have received research funding from the following pharmaceutical companies and CROs: Biogen, Ionis, Cytokinetics, Novartis, Takeda, Merk, IQVIA, ICON. O.H. has consulted and received honoraria from the following companies: Biogen, Cytokinetics, Denali, Orphazyme, Neurosense, Aclipse, Wave Pharmaceuticals, Novartis. O.H. is the Editor in Chief of the Journal Amyotrophic Lateral Sclerosis and the Frontotemporal Degenerations. A.A., M.G., M.H. and C.M. declare no competing interests.

Figures

Figure 1
Figure 1
Barplot of MQoL-SIS scores. The vertical line between 6 and 7 demonstrates the way the data was split. The value 6 was the median of the distribution and was included in the low QoL class.
Figure 2
Figure 2
Precision-Recall Curves for the predictive models that were developed to identify the predictors of QoL.
Figure 3
Figure 3
Bar plot and summary plot of model M7 for the identification of predictors of caregiver QoL. (A) Bar plot showing features in order of importance based on the mean absolute value of the SHAP values for each feature. (B) Summary plot where features appear in order of their sum of SHAP value magnitudes, and SHAP values show the impact each feature has on the model output. The colour represents the feature value (red high, blue low). The suffix “.C” represents a caregiver characteristic.
Figure 4
Figure 4
Bar plot and summary plot of model “M10-CDSS”. (A) Bar plot showing features in order of importance based on the mean absolute value of the SHAP values for each feature. (B) Summary plot where features appear in order of their sum of SHAP value magnitudes, and SHAP values show the impact each feature has on the model output. The colour represents the feature value (red high, blue low).
Figure 5
Figure 5
Precision-Recall Curves of CDSS models.

References

    1. Talbott, E., Malek, A. & Lacomis, D. The epidemiology of amyotrophic lateral sclerosis. In Handbook of Clinical Neurology Vol. 138 225–238 (Elsevier, 2016). - PubMed
    1. Mitchell JD, et al. Timelines in the diagnostic evaluation of people with suspected amyotrophic lateral sclerosis (als)/motor neuron disease (mnd)–A 20-year review: Can we do better? Amyotroph. Lateral Scler. 2010;11:537–541. doi: 10.3109/17482968.2010.495158. - DOI - PubMed
    1. Lulé D, Kübler A, Ludolph AC. Ethical principles in patient-centered medical care to support quality of life in amyotrophic lateral sclerosis. Front. Neurol. 2019;10:259. doi: 10.3389/fneur.2019.00259. - DOI - PMC - PubMed
    1. Olsson Ozanne, A. G., Strang, S. & Persson, L. I. Quality of life, anxiety and depression in als patients and their next of kin. J. Clin. Nurs.20, 283–291 (2011). - PubMed
    1. Coco GL, et al. Individual and health-related quality of life assessment in amyotrophic lateral sclerosis patients and their caregivers. J. Neurol. Sci. 2005;238:11–17. doi: 10.1016/j.jns.2005.05.018. - DOI - PubMed

Publication types